These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38753042)

  • 21. Antiemesis.
    Ettinger DS; Bierman PJ; Bradbury B; Comish CC; Ellis G; Ignoffo RJ; Kirkegaard S; Kloth DD; Kris MG; Lim D; Markiewicz MA; McNulty R; Nabati L; Todaro B; Urba S; Yowell S;
    J Natl Compr Canc Netw; 2007 Jan; 5(1):12-33. PubMed ID: 17239323
    [No Abstract]   [Full Text] [Related]  

  • 22. [An assessment tool for chemotherapy-induced nausea and vomiting and intervention outcomes].
    Aimono Y; Suzuki S; Nemoto M; Saito Y; Aoyama Y; Joko F; Maruyama T; Kamoshida T
    Gan To Kagaku Ryoho; 2013 Dec; 40(13):2551-4. PubMed ID: 24335368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of breakthrough and prevention of refractory chemotherapy-induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update.
    Patel P; Robinson PD; Phillips R; Baggott C; Devine K; Gibson P; Guilcher GMT; Holdsworth MT; Neumann E; Orsey AD; Spinelli D; Thackray J; van de Wetering M; Cabral S; Sung L; Dupuis LL
    Pediatr Blood Cancer; 2023 Aug; 70(8):e30395. PubMed ID: 37178438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The compliance with antiemetic guidelines of Turkish medical oncologists. A survey study of Turkish Oncology Group.
    Araz M; Karaagac M; Korkmaz L; Beypinar I; Uysal M
    Curr Probl Cancer; 2019 Aug; 43(4):344-353. PubMed ID: 30497851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey.
    Vidall C; Fernández-Ortega P; Cortinovis D; Jahn P; Amlani B; Scotté F
    Support Care Cancer; 2015 Nov; 23(11):3297-305. PubMed ID: 25953380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
    Natale JJ
    Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assessment of chemotherapy-induced nausea and vomiting(CINV)using MASCC antiemesis tool].
    Yamaguchi M; Ogawa T; Watanabe M; Anami S; Kamigaki S; Nishikawa N; Ono T; Furukawa H
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1691-6. PubMed ID: 19838029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The survey for anti-emetic guideline by using questioner].
    Saeki T; Tamura K; Aiba K; Aogi K; Iino K; Imamura C; Eguchi K; Okita K; Kagami Y; Tanaka R; Nakagawa K; Fujii H; Boku N; Matsuura K; Wada M; Akechi T; Kakudo Y; Kim YI; Sasaki H; Shima Y; Takeda M; Nagasaki E; Nishidate T; Saito M; Ashikaga Y; Tanigawara Y; Hirata K; Ishioka C; Nishiyama M
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):305-11. PubMed ID: 25812498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents.
    Scotté F; Schwartzberg L; Iihara H; Aapro M; Gralla R; Hesketh PJ; Jordan K; Chow R; Herrstedt J
    Support Care Cancer; 2023 Dec; 32(1):45. PubMed ID: 38114821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.
    Kobayashi M; Kako J; Iba A; Okuyama A; Ozawa K; Abe M; Wada M; Akechi T; Iihara H; Imamura CK; Kim YI; Sasaki H; Satomi E; Takeda M; Tanaka R; Nakajima TE; Nakamura N; Nishimura J; Noda M; Hayashi K; Higashi T; Boku N; Matsumoto K; Matsumoto Y; Okita K; Yamamoto N; Aogi K; Iino K
    Int J Clin Oncol; 2024 Jul; 29(7):889-898. PubMed ID: 38722486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nausea and vomiting with high-dose chemotherapy and stem cell rescue therapy: a review of antiemetic regimens.
    Trigg ME; Inverso DM
    Bone Marrow Transplant; 2008 Oct; 42(8):501-6. PubMed ID: 18724391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis.
    Grunberg SM
    Ann Oncol; 2007 Feb; 18(2):233-40. PubMed ID: 17108149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncologist perspectives on chemotherapy-induced nausea and vomiting (CINV) management and outcomes: A quantitative market research-based survey.
    Aapro M; Ruffo P; Panteri R; Costa S; Piovesana V
    Cancer Rep (Hoboken); 2018 Dec; 1(4):e1127. PubMed ID: 32729252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Best practice management of CINV in oncology patients: II. Antiemetic guidelines and rationale for use.
    Wickham R
    J Support Oncol; 2010; 8(2 Suppl 1):10-5. PubMed ID: 20629453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Nationwide, Multicenter Registry Study of Antiemesis for Carboplatin-Based Chemotherapy-Induced Nausea and Vomiting in Japan.
    Iihara H; Shimokawa M; Hayashi T; Kawazoe H; Saeki T; Aiba K; Tamura K
    Oncologist; 2020 Feb; 25(2):e373-e380. PubMed ID: 32043774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Olanzapine for preventing nausea and vomiting induced by moderately and highly emetogenic chemotherapy.
    Wang SY; Yang ZJ; Zhang L
    Asian Pac J Cancer Prev; 2014; 15(22):9587-92. PubMed ID: 25520071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost of antiemetic therapy for chemotherapy-induced nausea and vomiting in patients receiving platinum-containing regimens in daily practice in Japan: a retrospective study.
    Hamada S; Hinotsu S; Hori K; Furuse H; Oikawa T; Kawakami J; Ozono S; Akaza H; Kawakami K
    Support Care Cancer; 2012 Apr; 20(4):813-20. PubMed ID: 21472498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of using the Multinational Association of Supportive Care in Cancer Antiemesis Tool for assessment of chemotherapy-induced nausea and vomiting at the Tom Baker Cancer Centre.
    Warr JK; Chambers CR; Cusano FL; Cuthbert CA; Mah MS
    J Oncol Pharm Pract; 2015 Oct; 21(5):348-57. PubMed ID: 24938292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiemesis clinical practice guidelines in oncology.
    Ettinger DS; Bierman PJ; Bradbury B; Ellis G; Ignoffo RJ; Kirkegaard S; Kloth D; Krauss A; Kris MG; Lim D; Markiewicz MA; McNulty R; Noonan K; Stucky-Marshall L; Todaro B; Urba S; Yowell S;
    J Natl Compr Canc Netw; 2004 Sep; 2(5):470-90. PubMed ID: 19780255
    [No Abstract]   [Full Text] [Related]  

  • 40. Effective interventions for CINV: NCCN Antiemesis Clinical Practice Guidelines in Oncology.
    ONS News; 2004; 19(9 Suppl):17-8. PubMed ID: 15478570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.